ArticleNature genetics2020
N
Abstract read
In one paragraph
Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 186 papers.
0numbers the graph read from it
0cells of the map it votes in
186citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
186 citing papers in PubMed, 261 citations in OpenAlex.
- Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies.Biomarker research · 2026Review
- MATR3 is essential for oocyte growth and maturation quality through a dual molecular mechanism.eLife · 2026Article
- Beyond mBiomedicines · 2026Review
- RNA Chemical Modifications in Mammalian Skeletal Muscle Development, Homeostasis, and Disease: Regulatory Mechanisms and Chemical Biology Perspectives.Molecules (Basel, Switzerland) · 2026Review
- Ubiquitination and NOncology letters · 2026Review
- Regulatory elements on chromatin-associated RNA 15 years beyond RNA epigenetics.Nature chemical biology · 2026Review
- m6A deficiency induces dopaminergic neurodegeneration and progressive parkinsonism through a pathogenic loop with mitochondria.The Journal of clinical investigation · 2026Article
- YTHDC1 recognizes METTL16-dependent mProceedings of the National Academy of Sciences of the United States of America · 2026Article
- Unravelling Multilayered RNA Modification Networks in Female Reproduction and Obstetric/Gynaecologic Disorders.Biomolecules · 2026Review
- RNA modification-mediated multidimensional crosstalk: a novel perspective on gene expression regulation.Genome biology · 2026Review
- NNature reviews. Cancer · 2026Review
- The Regulatory Role of mCells · 2026Review
- EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathway.The Journal of clinical investigation · 2026Article
- The role of m6A RNA methylation in the maintenance of X chromosome inactivation and X-to-autosome dosage compensation in early embryonic lineages.Stem cell reports · 2026Article
- RM2Target v2.0: an updated database for the target genes of writers, erasers, and readers of RNA modifications.Nucleic acids research · 2026Article
- Diverse roles of YTHDC1 in chromatin and blood cancers.Frontiers in genetics · 2026Review
- Therapy-induced mRNA, rRNA and tRNA methylation alterations confer tolerance phenotype in tumor cells: mechanism and implications.International journal of biological sciences · 2026Review
- The Role of Histone Methylation in Heart Failure: Epigenetic Mechanisms and Therapeutic Perspectives.Drug design, development and therapy · 2026Review
- WTAP-Mediated Glutaminase Splicing Bias Suppresses Ferroptosis in Hepatocellular Carcinoma.Cancer communications (London, England) · 2026Article
- The METTL3-YTHDC1 axis mediates architectural RNA mMolecular cancer · 2025Article
126 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
21 authors at 3 institutions in 1 country.
Yuan Li *Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Linjian Xia *Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Kaifen Tan *Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Xidong Ye *Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Zhixiang Zuo *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.ORCID http://orcid.org/0000-0002-2492-2689
Minchun Li *Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Rui XiaoFrontier Science Center for Immunology and Metabolism, Medical Research Institute, and Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, P. R. China.
Zihan WangDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Xiaona LiuDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Mingqiang DengDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Jinru CuiDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Mengtian YangDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Qizhi LuoDepartment of Forensic Toxicology, School of Forensic Medicine, Southern Medical University, Guangzhou, P. R. China.
Sun LiuDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Xin CaoDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Haoran ZhuDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Tianqi LiuDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Jiaxin HuDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Junfang ShiDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China.
Shan XiaoDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China. asdfg@smu.edu.cn.ORCID http://orcid.org/0000-0002-4012-7650
Laixin XiaDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P. R. China. xialx@smu.edu.cn.ORCID http://orcid.org/0000-0003-2735-9518
Southern Medical University · CNSun Yat-sen University · CNWuhan University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
A dynamic epigenome is critical for appropriate gene expression in development and health
Indexed as
AdenosineCell LineChromatinGene ExpressionHEK293 CellsHistonesHumansMethylationMethyltransferasesRNA, MessengerTranscription, GeneticAdenosineChromatinHistonesMethyltransferasesN-methyladenosineRNA, Messenger
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.